The power of orthogonal approaches to accelerate development of targeted therapies

A common challenge found in the world of scientific research is achieving recognition for topics not typically

Find out more

Ready to Watch Webinars focused on particle characterisation: Tips and tricks

These webinars are designed for you to sharpen your analytical methods, deepen your knowledge, or

Find out more

Scaling non-viral gene delivery from preclinical stages to commercial manufacturing

Lipid-based genetic medicines have garnered recent attention with the expedited creation of COVID-19 vaccines

Find out more

Let’s build mRNA vaccine formulation and manufacturing capability locally in Australia

A new age of mRNA vaccine development upon us.   As a COVAX member, Australia will have access to buy

Find out more

Develop and Manufacture RNA Medicines for the Treatment of COVID-19 faster and more reliably

Learn how the PNI NanoAssemblr Ignite supports: 1. Development of COVID-19 RNA-LNP vaccine2. Proprietary

Find out more

How the Right Technology Can Help Australian Researchers Meet the Present Urgency Surrounding a COVID Vaccine

Vaccine development is a complicated process that can span a decade or even longer. Typically development

Find out more

RNA Treatments and Vaccines for Infectious Disease Response

RNA-based genetic vaccines may represent the most promising approach for the rapid development and deployment

Find out more